Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01448 |
| Species: | Homo sapiens |
| Position : | chr6:32543534-32553534 |
| Year: | 2020 |
| Title: | A super enhancer controls expression and chromatin architecture within the MHC class II locus |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | -- |
| PMID: | 31753848 |
| MONDO: | |
| Tissue: | Lymphoid tissue |
| Tissue Ontology ID: | UBERON:0001745 |
| Cell Source: | Not available |
| CVCL ID: | |
| Cell Type: | |
| Cell Ontology ID: | |
| Experiment Type: | Functional perturbation assay, Chromatin interaction assay, Enhancer activity assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | CRISPR Knockout, ChIP-RT-qPCR, RT-RT-qPCR, 3C, Flow Cytometry |
| Target gene : | HLA-DRB1 |
| TF name : | CIITA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| CIITA | Interferon gamma signaling | reactome | 88 |
| CIITA | Antigen processing and presentation | kegg | 75 |
| CIITA | Toxoplasmosis | kegg | 131 |
| CIITA | Hs_Type_II_interferon_signaling_(IFNG)_WP619_71168 | wikipathways | 10 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01436 | chr6:32543534-32553534 | Lymphoid tissue | -- | -- |